-
Company Insights
Innovation and Patenting activity of ATN International Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ATN International Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
ATN International Inc – Company Profile
ATN International Inc (ATN) is a holding company, which owns and operates wireless and wireline telecommunications service providers. It also provides advanced data services, and video and voice services to residential and business customers. ATN is the owner and operator of terrestrial and submarine fiber optic transport systems in the US and the Caribbean. The company market its product under Commnet, Choice, GT&T, Viya, Logic, Fireminds, Alaska Communications, and EssexTel. It operates in Bermuda, the US Virgin Islands, Guyana and...
Add to Basket -
Company Profile
Atlantica Sustainable Infrastructure plc – Company Profile
Atlantica Sustainable Infrastructure plc (Atlantica), formerly Atlantica Yield plc, is a sustainable infrastructure company. It owns, manages and acquires a portfolio of contracted assets in the power and environment sectors. The company owns various assets comprising renewable energy generation, conventional power generation, efficient natural gas, electric transmission lines and water assets. Atlantica’s asset portfolio includes Solana, Mojave, Solaben, Helios, Solnova, Kaxu, Palmatir, Cadonal, ATN, ATS, Quadra, Palmucho, Skikda and Honaine. It has operations in North America, South America, Europe and...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ATN-249
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ATN-249 Drug Details ATN-249 is under development for the treatment of hereditary angioedema (HAE)....
-
Product Insights
Net Present Value Model: Ozoralizumab
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ozoralizumab Drug Details Ozoralizumab (Nanozora) is...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hereditary Angioedema (HAE) Pipeline Drugs Development Market Overview Hereditary Angioedema (HAE) is a rare inherited disease that causes considerable swelling in various body tissues, such as the abdomen or face. Symptoms include severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing and difficulty breathing. Treatment includes medications, such as epinephrine, antihistamines, and corticosteroids. The Hereditary Angioedema pipeline drugs market research report provides comprehensive information on the therapeutics under development for Hereditary Angioedema, complete with analysis by...
-
Sector Analysis
Kyrgyzstan Insurance Market Size by Segment (Life, General and Reinsurance), Trends, Competitive Landscape and Forecast, 2022-2026
The gross written premium of Kyrgyzstan insurance industry was $14.9 million in 2021. The market is expected to achieve a CAGR of more than 8% during the forecast period. The Kyrgyzstan Insurance Industry research report provides in-depth market analysis, information, insights, and a detailed outlook by product category of the industry. It provides values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability ratios, and premium by line of business, during the review period...